Literature DB >> 8913260

Matrilysin is associated with progression of colorectal tumor.

T Ishikawa1, Y Ichikawa, M Mitsuhashi, N Momiyama, T Chishima, K Tanaka, H Yamaoka, K Miyazakic, Y Nagashima, T Akitaya, H Shimada.   

Abstract

Matrilysin and gelatinase A, B mRNA expressions were examined in colorectal tumors. Matrilysin mRNA was observed exclusively in tumors, while the others were also found in normal mucosa surrounding tumors. Further analysis revealed that colorectal adenomas with severe dysplasia, not with mild dysplasia, expressed matrilysin with lower levels than cancers. The level of matrilysin mRNA expression increased with the advancement of stages of colorectal cancers, consequently a relatively higher expression was observed in liver metastatic tumors than primary tumors. These results suggest that matrilysin mRNA expression was correlated with the progression of colorectal tumors, and this enzyme may also play a role in developing metastatic tumors in liver.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8913260     DOI: 10.1016/0304-3835(96)04336-4

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  21 in total

1.  Matrix metalloproteinases in gastrointestinal cancer.

Authors:  P D Brown
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

Review 2.  The role of matrix metalloproteinase genes in glioma invasion: co-dependent and interactive proteolysis.

Authors:  T E VanMeter; H K Rooprai; M M Kibble; H L Fillmore; W C Broaddus; G J Pilkington
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  MMP7 Modulation by Short- and Long-term Radiotherapy in Patients with Rectal Cancer.

Authors:  Christina Stene; Andrea Polistena; Alexander Gaber; Björn Nodin; Bianca Ottochian; Diya Adawi; Nicola Avenia; Karin Jirström; Louis Banka Johnson
Journal:  In Vivo       Date:  2018 Jan-Feb       Impact factor: 2.155

4.  MMP-7 as a prognostic marker in colorectal cancer.

Authors:  Selja Koskensalo; Johanna Louhimo; Stig Nordling; Jaana Hagström; Caj Haglund
Journal:  Tumour Biol       Date:  2010-08-28

Review 5.  Matrix metalloproteinase inhibitors in the treatment of cancer.

Authors:  P D Brown
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

6.  Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer.

Authors:  D L Ornstein; J MacNab; K H Cohn
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

7.  Multistep carcinogenesis of perihilar cholangiocarcinoma arising in the intrahepatic large bile ducts.

Authors:  Yasuni Nakanuma; Motoko Sasaki; Yasunori Sato; Xiangshan Ren; Hiroko Ikeda; Kenichi Harada
Journal:  World J Hepatol       Date:  2009-10-31

Review 8.  Is there a genetic signature for liver metastasis in colorectal cancer?

Authors:  Cristina Nadal; Joan Maurel; Pere Gascon
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

9.  Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer.

Authors:  Y J Fang; Z H Lu; G Q Wang; Z Z Pan; Z W Zhou; J P Yun; M F Zhang; D S Wan
Journal:  Int J Colorectal Dis       Date:  2009-05-07       Impact factor: 2.571

10.  Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.

Authors:  Fancong Kong; Zhichao Chen; Qiubai Li; Xiaolong Tian; Juan Zhao; Ke Yu; Yong You; Ping Zou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.